Esteban Jódar-Gimeno

Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial

Bente Langdahl, Cesar Libanati, Daria B. Crittenden et al. · The Lancet · 2017 · 450 citations

Bone Disease, Sclerostin, Bone Health +7

Effect of Liraglutide on Cardiovascular Outcomes in Elderly Patients: A Post Hoc Analysis of a Randomized Controlled Trial

Matthew P. Gilbert, Stephen C. Bain, Edward Franek et al. · Annals of Internal Medicine · 2018 · 57 citations

Aging, Cardiovascular Disease, Geriatrics +15

Ketoconazole therapy: hormonal and clinical effects in non-tumoral hyperandrogenism

Antonio Vidal‐Puig, Manuel Muñoz‐Torres, Esteban Jódar-Gimeno et al. · European Journal of Endocrinology · 1994 · 25 citations

Quality of life and fear for hypoglycemia in patients with type 2 diabetes mellitus

Esteban Jódar-Gimeno, Fernando Álvarez Guisasola, L. Ávila-Lachica et al. · Revista Clínica Española (English Edition) · 2014 · 19 citations

Quality Of Life, Diabetes Management, Psychiatry +5

Hyperinsulinemia in polycystic ovary syndrome: relationship to clinical and hormonal factors

Antonio Vidal‐Puig, M. Mu�oz-Torres, Esteban Jódar-Gimeno et al. · Journal of Molecular Medicine · 1994 · 12 citations

Infertility, Hormonal Factors, Endocrine Disease +11